Literature DB >> 1484563

Cholinergic sensitivity of irides from donors with various pathological conditions and lens implants.

P N Patil1, T F Mauger.   

Abstract

In vitro, iris contractions after muscarinic agonists were measured in mg of tension change and the concentration producing 50% of the response was expressed as EC50 mumol/l. Although the average EC50 value of carbachol in the iris sphincter of the donors with diabetes or Parkinson's disease did not change significantly when compared with the control, the maximum contraction of the tissue from the diseased state was increased significantly. Thus, in addition to the well known denervation supersensitivity of the iris-dilator, the iris-sphincter also develops adaptive sensitivity changes. Antimuscarinic drug treatment in some Parkinson's patients interfered with the estimation of supersensitivity in vitro studies. The enhanced response of carbachol at the low temperatures or the relative potency of carbachol and pilocarpine in the tissue obtained from the diseased donors was not significantly different from that of controls. Based on EC50 values, the potency of arecoline on the iris was 1/3 that of carbachol. Significantly lower EC50 values of carbachol were found in irides which were in contact with open loop type anterior chamber lens implants compared with those in contact with the closed loop anterior chamber lens implants. Maximum responses of irides to carbachol were less when the tissue was in contact with open loop lens compared with those in contact with closed loop anterior chamber implants. Irides from many donors having unilateral or bilateral replacement of the artificial lenses responded with EC50 of carbachol which was approximately equal to that of the contralateral eye. The maximum difference between EC50 values of the left and right iris was less than 5 fold.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1484563     DOI: 10.1007/bf00168734

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  Supersensitivity and subsensitivity to sympathomimetic amines.

Authors:  U TRENDELENBURG
Journal:  Pharmacol Rev       Date:  1963-06       Impact factor: 25.468

2.  TiPS Receptor Nomenclature Supplement. January 1992.

Authors:  A Watson; A Abbott
Journal:  Trends Pharmacol Sci       Date:  1991-12       Impact factor: 14.819

Review 3.  Biochemical measurement of muscarinic receptor efficacy and its role in receptor regulation.

Authors:  S B Freedman; E A Harley; L L Iversen
Journal:  Trends Pharmacol Sci       Date:  1988-02       Impact factor: 14.819

Review 4.  Postjunctional supersensitivity and subsensitivity of excitable tissues to drugs.

Authors:  W W Fleming; J J McPhillips; D P Westfall
Journal:  Ergeb Physiol       Date:  1973

5.  Contractile responses of isolated vascular smooth muscle during prolonged exposure to anoxia.

Authors:  R Detar; D F Bohr
Journal:  Am J Physiol       Date:  1972-05

6.  A muscarinic receptor different from the M1, M2, M3 and M4 subtypes mediates the contraction of the rabbit iris sphincter.

Authors:  I T Bognar; U Altes; C Beinhauer; I Kessler; H Fuder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

7.  Iris pigmentation and atropine mydriasis.

Authors:  M Salazar; K Shimada; P N Patil
Journal:  J Pharmacol Exp Ther       Date:  1976-04       Impact factor: 4.030

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  Characterization of cholinergic muscarinic receptors in the rabbit iris.

Authors:  R E Honkanen; A A Abdel-Latif
Journal:  Biochem Pharmacol       Date:  1988-07-01       Impact factor: 5.858

Review 10.  Polymethylene tetraamines as muscarinic receptor probes.

Authors:  C Melchiorre; A Minarini; P Angeli; D Giardinà; U Gulini; W Quaglia
Journal:  Trends Pharmacol Sci       Date:  1989-12       Impact factor: 14.819

View more
  2 in total

1.  Visual symptoms in Parkinson's disease.

Authors:  R A Armstrong
Journal:  Parkinsons Dis       Date:  2011-05-25

Review 2.  Oculo-Visual Dysfunction in Parkinson's Disease.

Authors:  R A Armstrong
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.